About Phase Genomics
Phase Genomics is a private company based in Seattle, Washington. It has reported $5,754,365 raised in two offerings on Form D since November 2017. Its chief executive is Ivan Liachko.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 14, 2023 | Mar 21, 2023 | $4,754,364of $6.5M target | 13 | $365K | Equity, Debt, Options, Securities on exercise, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Nov 9, 2017 | Nov 22, 2017 | $1,000,001of $1.4M target | 4 | $250K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $5,754,365 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Phase Genomics's Form D filed Mar 21, 2023.
SS
Shawn Sullivan
Executive officer and promoter
IL
Ivan Liachko
Chief Executive Officer and director
KY
Kayla Young
Executive officer